Search Results 571-580 of 31486 for Ovary
This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, fallopian tube, or ...
This study is a double-blind, randomized, placebo-controlled (2:1 niraparib:placebo) study in patients with Stage III or IV ovarian cancer. Patients must have ...
Ovarian cancer remains a very deadly disease in part because it's often diagnosed at later stages. If the cancer has spread, it's even harder to treat. But ...
This phase II trial studies how well olaparib and cediranib maleate work in treating patients with ovarian, primary peritoneal, or fallopian tube cancer that ...
Mayo scientists explore swabs for early endometrial, ovarian cancer detection featured image. Individualized Medicine. Mayo scientists explore swabs for early ...
This phase II trial studies how well temsirolimus and bevacizumab work in treating patients with advanced endometrial, ovarian, liver, carcinoid, or islet cell ...
Peritoneal carcinomatosis usually comes from cancers that start in other organs, such as the colon, stomach or ovaries. ... Ovarian cancer. Colon or rectal ...
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer. Print details. Share ...
Giving ribociclib together with letrozole may be an effective treatment in patients with ovarian, fallopian tube, primary peritoneal, or endometrial cancer.
You might be at risk of cancer of the cervix, ovaries or uterus if you have not had surgery to remove them. ... ovarian tissue for future use. This might ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.